Literature DB >> 12436175

Prognostic factors influencing morbidity and mortality in esophageal carcinoma.

Andrea Cariati1, Alessandro Casano, Antonello Campagna, Erminio Cariati, Gianluigi Pescio.   

Abstract

PURPOSE: In 1980, operative mortality for esophageal resection was 29%. Over the last 15 years, technical and critical care improvements contributed to the reduction of postoperative mortality rate to 8%. The aim of this study is to analyze retrospectively the role of different factors (surgical procedure, stage of the disease, and anesthetic risk) on the postoperative mortality of 63 patients that underwent esophagectomy with gastric interposition for cancer.
METHODS: Seventy-two patients underwent esophagectomy. The stomach was the esophageal substitute in 63 cases. Surgical procedures included transthoracic esophagectomy in 49 patients and transhiatal esophagectomy in 14 cases. Among the 49 transthoracic esophagectomy patients, there were 18 patients with a high anesthetic risk (ASA III). Among the patients that underwent transhiatal esophagectomy, there were 10 patients with a high anesthetic risk (ASA III).
RESULTS: The operative mortality rate was 14% (2/14) in transhiatal esophagectomy group and 22% (1(1/4)9) in transthoracic esophagectomy group (P = ns). The postoperative mortality of patients with a high anesthetic risk (ASA III) was 47% (8/17) after transthoracic esophagectomy and 10% (1/10) after transhiatal esophagectomy (P <0.05). DISCUSSION: In our experience, the operative mortality was nearly 18% (16.6% after transhiatal esophagectomy and 20.8% after transthoracic esophagectomy). Among the patients with a high anesthetic risk (ASA III) that underwent surgery, the postoperative mortality was significantly lower after transhiatal esophagectomy (10%) compared to transthoracic esophagectomy (47%) (P <0.05).

Entities:  

Mesh:

Year:  2002        PMID: 12436175     DOI: 10.1590/s0041-87812002000500002

Source DB:  PubMed          Journal:  Rev Hosp Clin Fac Med Sao Paulo        ISSN: 0041-8781


  3 in total

1.  The use of LigaSure Vessel Sealing System in Ivor Lewis esophagectomy.

Authors:  Fuat Sayir; Ufuk Cobanoğlu; Abidin Sehitoğulları
Journal:  J Cardiothorac Surg       Date:  2012-01-24       Impact factor: 1.637

Review 2.  Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior.

Authors:  Francisca Dias; Mariana Morais; Ana Luísa Teixeira; Rui Medeiros
Journal:  Cancers (Basel)       Date:  2018-10-12       Impact factor: 6.639

3.  Standardized clinical pathways for esophagectomy are not a reality in Brazil, even with a high prevalence of esophageal cancer and achalasia.

Authors:  Marina Zamuner; Fernando A M Herbella; José L B Aquino
Journal:  Arq Bras Cir Dig       Date:  2015 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.